Protease-activated receptor-2 modulates myocardial ischemia-reperfusion injury in the rat heart.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2000-03-28

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1073/PNAS.97.7.3678PMID 10737808PMCID PMC16299
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reperfusion Injury: Basic Concepts and Protection Strategies

  2004cited by this paper
• Kinetics of tumor necrosis factor α in plasma and the cardioprotective effect of a monoclonal antibody to tumor necrosis factor α in acute myocardial infarction

  1999cited by this paper
• A protective role for protease-activated receptors in the airways

  1999cited by this paper
• Cardiovascular responses mediated by protease-activated receptor-2 (PAR-2) and thrombin receptor (PAR-1) are distinguished in mice deficient in PAR-2 or PAR-1.

  1999cited by this paper
• Protease-activated receptor-2 involvement in hypotension in normal and endotoxemic rats in vivo.

  1999cited by this paper
• Tumor necrosis factor-alpha contributes to ischemia- and reperfusion-induced endothelial activation in isolated hearts.

  1999cited by this paper
• Characterization of the inflammatory response to proteinase‐activated receptor‐2 (PAR2)‐activating peptides in the rat paw

  1999cited by this paper
• Age-related decrease in cardiac tolerance to oxidative stress.

  1999cited by this paper
• Protease-Activated Receptor-2 Activation Evidence for Selective Effects of Chronic Hypertension on Cerebral Artery Vasodilatation

  1999cited by this paper
• Protease-activated receptors: PAR4 and counting: how long is the course?

  1999cited by this paper
• Kinetics of tumor necrosis factor alpha in plasma and the cardioprotective effect of a monoclonal antibody to tumor necrosis factor alpha in acute myocardial infarction.

  1999cited by this paper
• Inhibition of Myocardial TNF‐α Production by Heat Shock: A Potential Mechanism of Stress‐Induced Cardioprotection against Postischemic Dysfunction a

  1999cited by this paper
• Characterization of Protease-activated Receptor-2 Immunoreactivity in Normal Human Tissues

  1998cited by this paper
• Activation of protease-activated receptor-2 (PAR-2) elicits nitric oxide-dependent dilatation of the basilar artery in vivo.

  1998cited by this paper
• Receptor-activating peptides distinguish thrombin receptor (PAR-1) and protease activated receptor 2 (PAR-2) mediated hemodynamic responses in vivo.

  1998cited by this paper
• Atypical protease-activated receptor mediates endothelium-dependent relaxation of human coronary arteries.

  1998cited by this paper
• Tumor necrosis factor in the heart.

  1998cited by this paper
• Differential expression of functional protease-activated receptor-2 (PAR-2) in human vascular smooth muscle cells.

  1998cited by this paper
• New-onset angina preceding acute myocardial infarction is associated with improved contractile recovery after thrombolysis.

  1998cited by this paper
• Increased vascular permeability by a specific agonist of protease‐activated receptor‐2 in rat hindpaw

  1998cited by this paper
• Cleavage and activation of proteinase‐activated receptor‐2 on human neutrophils by gingipain‐R from Porphyromonas gingivalis

  1998cited by this paper
• Tumor Necrosis Factor- (cid:97) Confers Resistance to Hypoxic Injury in the Adult Mammalian Cardiac Myocyte

  1998cited by this paper
• Specific inhibition of thrombin-induced cell activation by the neutrophil proteinases elastase, cathepsin G, and proteinase 3: evidence for distinct cleavage sites within the aminoterminal domain of the thrombin receptor.

  1997cited by this paper
• Luminal trypsin may regulate enterocytes through proteinase-activated receptor 2.

  1997cited by this paper
• Mast cell tryptase regulates rat colonic myocytes through proteinase-activated receptor 2.

  1997cited by this paper
• A simple and rapid purification procedure minimizes spontaneous oxidative modifications of low density lipoprotein and lipoprotein (a).

  1997cited by this paper
• Vascular effects of proteinase-activated receptor 2 agonist peptide.

  1997cited by this paper
• Chronic infections and coronary heart disease: is there a link?

  1997cited by this paper
• Identification of potential activators of proteinase‐activated receptor‐2 1

  1997cited by this paper
• Interactions of Mast Cell Tryptase with Thrombin Receptors and PAR-2*

  1997cited by this paper
• The Proteinase-activated Receptor 2 Is Induced by Inflammatory Mediators in Human Endothelial Cells

  1996cited by this paper
• Evidence for the presence of a proteinase-activated receptor distinct from the thrombin receptor in vascular endothelial cells.

  1996cited by this paper
• Rat proteinase‐activated receptor‐2 (PAR‐2): cDNA sequence and activity of receptor‐derived peptides in gastric and vascular tissue

  1996cited by this paper
• Leukemia inhibitory factor and tumor necrosis factor induce manganese superoxide dismutase and protect rabbit hearts from reperfusion injury.

  1995cited by this paper
• Molecular cloning of a potential proteinase activated receptor.

  1994cited by this paper
• Endogenous tumor necrosis factor exerts its protective function intracellularly against the cytotoxicity of exogenous tumor necrosis factor.

  1992cited by this paper
• Tumor necrosis factor-alpha pretreatment is protective in a rat model of myocardial ischemia-reperfusion injury.

  1992cited by this paper
• Tumor necrosis factor-α pretreatment is protective in a rat model of myocardial ischemia-reperfusion injury

  1992cited by this paper
• Single-dose tumor necrosis factor protection against endotoxin-induced shock and tissue injury in rats

  1991cited by this paper
• Inflammation in the course of early myocardial ischemia

  1991cited by this paper
• Endotoxin pretreatment increases endogenous myocardial catalase activity and decreases ischemia-reperfusion injury of isolated rat hearts.

  1989cited by this paper
• Measurement and characterization of postischemic free radical generation in the isolated perfused heart.

  1989cited by this paper
• Induction of manganous superoxide dismutase by tumor necrosis factor: possible protective mechanism

  1988cited by this paper
• Myocardial consequences of reperfusion.

  1987cited by this paper
• Energy‐linked cardiac transport system for glutathione disulfide

  1986cited by this paper
• An exonuclease protection assay reveals heat-shock element and TATA box DNA-binding proteins in crude nuclear extracts

  1985cited by this paper
• Cardiac transport of glutathione disulfide and S-conjugate. Studies with isolated perfused rat heart during hydroperoxide metabolism.

  1984cited by this paper
• Overview of methods used for detecting lipid peroxidation.

  1984cited by this paper
• Glutathione redox cycle protects cultured endothelial cells against lysis by extracellularly generated hydrogen peroxide.

  1984cited by this paper
• Hydroperoxide metabolism in mammalian organs.

  1979cited by this paper
• Free Radicals and Inflammation: Protection of Synovial Fluid by Superoxide Dismutase

  1974cited by this paper
• Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues.

  1969cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Trypsin cleavage of the β1-adrenergic receptor.

  2022cites this paper
• IJOMS Vol 20-2-12.indd

  2021cites this paper
• Tissue factor cytoplasmic domain exacerbates post-infarct left ventricular remodeling via orchestrating cardiac inflammation and angiogenesis

  2021cites this paper
• CVR-2018-935R1 Title: Circulating blood cells and extracellular vesicles in acute cardioprotection Short title: Circulating cells and vesicles in cardioprotection

  2019cites this paper
• Proteinase-activated receptor 2 deficiency is a protective factor against cardiomyocyte apoptosis during myocardial ischemia/reperfusion injury

  2019cites this paper
• A review on protective role of genistein against oxidative stress in diabetes and related complications.

  2019cites this paper
• Protease-activated receptor 2 protects against myocardial ischemia-reperfusion injury through the lipoxygenase pathway and TRPV1 channels.

  2019cites this paper
• The mechanisms of cellular signaling by Factor VII activating protease (FSAP)

  2018cites this paper
• Circulating blood cells and extracellular vesicles in acute cardioprotection.

  2018cites this paper
• Cathepsin S Alters the Expression of Pro-Inflammatory Cytokines and MMP-9, Partially through Protease—Activated Receptor-2, in Human Corneal Epithelial Cells

  2018cites this paper
• Mast cells regulate myofilament calcium sensitization and heart function after myocardial infarction

  2016cites this paper
• The Role of Protease-Activated Receptors for the Development of Myocarditis: Possible Therapeutic Implications.

  2016cites this paper
• Coagulation and non‐coagulation effects of thrombin

  2016cites this paper
• The contribution of proteinase-activated receptors to intracellular signaling, transcellular transport and autophagy in Alzheimer's disease.

  2015cites this paper
• Pleiotropic effects of factor Xa and thrombin: what to expect from novel anticoagulants.

  2014cites this paper
• Disturbance of vasodilation via protease-activated receptor 2 in SHRSP.Z-Lepr fa/IzmDmcr rats with metabolic syndrome.

  2014cites this paper
• Tissue factor, protease activated receptors and pathologic heart remodelling

  2014cites this paper
• Proteinase-activated receptors (PARs) – focus on receptor-receptor-interactions and their physiological and pathophysiological impact

  2013cites this paper
• Protease Activated Receptor-2 Contributes to Heart Failure

  2013cites this paper
• Effects of chronic in-vivo treatments with protease-activated receptor 2 agonist on endothelium function and blood pressures in mice.

  2013cites this paper
• Coagulation and coagulation signalling in fibrosis.

  2013cites this paper
• Neuroprotective Effect of Protease-Activated Receptor-2 in the Hypoxia-Induced Apoptosis of Rat RGC-5 Cells

  2012cites this paper
• Kallikrein protease activated receptor (PAR) axis: an attractive target for drug development.

  2012cites this paper
• Protease‐Activated Receptor 2

  2012cites this paper
• The multiple layers of signaling selectivity at protease-activated receptors.

  2012cites this paper
• Transcriptome Analysis of Renal Ischemia/Reperfusion Injury and Its Modulation by Ischemic Pre-Conditioning or Hemin Treatment

  2012cites this paper
• Inflammation in Myocardial Diseases

  2012cites this paper
• The down regulation of neutrophil oxidative metabolism by S100A8 and S100A9: implication of the protease-activated receptor-2.

  2012cites this paper
• Effects of intracellular acidosis on endothelial function: an overview.

  2012cites this paper
• The multivalent activity of the tissue factor–thrombin pathway in thrombotic and non-thrombotic disorders as a target for therapeutic intervention

  2011cites this paper
• Protease activated receptor-2 mediates activated protein C-induced cutaneous wound healing via inhibition of p38.

  2011cites this paper
• Protease‐activated receptors and myocardial infarction

  2011cites this paper
• Protease-Activated Receptor-2 Modulates Protease-Activated Receptor-1–Driven Neointimal Hyperplasia

  2011cites this paper
• Protease-activated receptor 2 signaling in inflammation

  2011cites this paper
• Structure, function and pathophysiology of protease activated receptors.

  2011cites this paper
• Cell Injury , Repair , Aging , and Apoptosis Protease Activated Receptor-2 Mediates Activated Protein C – Induced Cutaneous Wound Healing via Inhibition of p 38

  2011cites this paper
• Role of Tumour Necrosis Factor Alpha (TNFa) in ischaemic and pharmacological postconditioning

  2010cites this paper
• Anticoagulant therapy in critical organ ischaemia/reperfusion injury

  2010cites this paper
• Protease-Activated Receptor 2 Deficiency Reduces Cardiac Ischemia/Reperfusion Injury

  2010cites this paper
• Papel dos receptores ativados por protease (PARs) na reatividade vascular de ratos espontaneamente hipertensos (SHR)

  2010cites this paper
• Proteinase-activated receptor-2 mediated inhibition of TNFα-stimulated JNK activation — A novel paradigm for Gq/11 linked GPCRs

  2010cites this paper
• Proinflammatory role of protease-activated receptor-2 in intestinal ischemia/reperfusion injury in rats.

  2010cites this paper
• Cardioprotective effect of sasanquasaponin preconditioning via bradykinin‐NO pathway in isolated rat heart

  2009influential citation
• Mechanisms underlying enhanced vasorelaxant response to protease-activated receptor 2-activating peptide in type 2 diabetic Goto-Kakizaki rat mesenteric artery.

  2009cites this paper
• Promoter methylation of protease-activated receptor (PAR2) is associated with severe clinical phenotypes of ulcerative colitis (UC)

  2009cites this paper
• Activation of Protease Activated Receptor-2 Induces Delayed Cardioprotection in Anesthetized Mice

  2009influential citation
• Recent advances in synthesis of PAR ligands as therapeutic strategy for inflammatory diseases.

  2009cites this paper
• Prominent cardioprotective effects of third generation beta blocker nebivolol against anthracycline-induced cardiotoxicity using the model of isolated perfused rat heart.

  2008cites this paper
• Kallikreins and proteinase-mediated signaling: proteinase-activated receptors (PARs) and the pathophysiology of inflammatory diseases and cancer

  2008cites this paper
• Frontiers in Research Review: Better Understanding of Disease Mechanism: From Phenotype to Genotype CARDIAC TISSUE FACTOR: ROLES IN PHYSIOLOGY AND FIBROSIS

  2008cites this paper
• CARDIAC TISSUE FACTOR: ROLES IN PHYSIOLOGY AND FIBROSIS

  2008cites this paper
• KALLIKREIN-RELATED PEPTIDASE SIGNALLING VIA PROTEINASE-ACTIVATED RECEPTORS

  2008cites this paper
• Proteinases, proteinase-activated receptors (PARs) and the pathophysiology of cancer and diseases of the cardiovascular, musculoskeletal, nervous and gastrointestinal systems

  2008cites this paper
• PAR-2 activation at the time of reperfusion salvages myocardium via an ERK1/2 pathway in in vivo rat hearts.

  2007influential citation
• Tissue factor deficiency and PAR-1 deficiency are protective against renal ischemia reperfusion injury.

  2007cites this paper
• Renin: at the heart of the mast cell

  2007cites this paper
• Distinct roles for PAR1‐ and PAR2‐mediated vasomotor modulation in human arterial and venous conduits

  2007cites this paper
• Potential physiological and pathophysiological roles for protease‐activated receptor‐2 in the kidney (Review Article)

  2007cites this paper
• 'Role reversal' for the receptor PAR1 in sepsis-induced vascular damage

  2007cites this paper
• Inflammation, proinflammatory mediators and myocardial ischemia-reperfusion Injury.

  2007cites this paper
• Vitamin C promotes human endothelial cell growth via the ERK-signaling pathway

  2007cites this paper
• Upregulation of proteinase-activated receptors and hypercontractile responses precede development of arterial lesions after balloon injury.

  2006cites this paper
• Protease-activated receptors (PARs) are partly pro-inflammatory and partly anti-inflammatory: will PAR agonists or antagonists participate in future drug therapies?

  2006cites this paper
• The up-regulation of proteinase-activated receptors and the hyper-contractile responses precede the development of arterial lesions after balloon injury

  2006cites this paper
• Activated Protein C in the Cardioplegic Solution on a Porcine Model of Coronary Ischemia-Reperfusion has Deleterious Hemodynamic Effects

  2006cites this paper
• Protease-activated receptor-2 activation: a major role in the pathogenesis of Porphyromonas gingivalis infection.

  2006cites this paper
• Enzymatic measurement of tryptase-like protease release from isolated perfused guinea pig heart during ischemia-reperfusion.

  2005cites this paper
• EPICARDIAL AUTO-FLUORESCENCE NAD(P)H KINETICS IN THE ISCHEMICALLY PRECONDITIONED LANGERDORFF RAT HEART. EFFECTS OF CAPSAICIN. PART 2.

  2005cites this paper
• Proteinases as hormone-like signal messengers Proteinase-activated receptors and the pathophysiology of inflammation , pain , cardiovascular disease and cancer

  2005cites this paper
• The Cardiovascular Actions of Protease-Activated Receptors

  2005cites this paper
• Proteinases as hormone-like signal messengers.

  2005cites this paper
• Protease‐activated receptors‐1 and ‐2 can mediate endothelial barrier protection: role in factor Xa signaling

  2005cites this paper
• Protease-activated receptor-2 (PAR2) in cardiovascular system.

  2005cites this paper
• Ischemia-reperfusion induces glomerular and tubular activation of proinflammatory and antiapoptotic pathways: differential modulation by rapamycin.

  2004cites this paper
• Evidence that protease activated receptor 2 expression is enhanced in human coronary atherosclerotic lesions

  2004cites this paper
• Transient focal ischemia in rat brain differentially regulates mRNA expression of protease‐activated receptors 1 to 4

  2004cites this paper
• Protease-activated receptors: contribution to physiology and disease.

  2004cites this paper
• Protease activated receptors in cardiovascular function and disease

  2004cites this paper
• Upregulation of proteinase‐activated receptors (PARs) and cardiovascular function

  2003cites this paper
• Protease‐activated receptor subtype expression in developing eye and adult retina of the rat after optic nerve crush

  2003cites this paper
• プロテアーゼ受容体PAR-2(protease-activated receptor-2)の生理機能

  2003cites this paper
• The PAR-1-activating peptide facilitates pepsinogen secretion in rats.

  2003cites this paper
• Trypsin induces tumour necrosis factor-alpha secretion from a human leukemic mast cell line.

  2003cites this paper
• Differential expression and regulation of protease-activated receptors in human peripheral monocytes and monocyte-derived antigen-presenting cells.

  2003cites this paper
• The signal of proteinase-activated receptor-2 plays an important role in pancreatic cancer progression

  2003cites this paper
• A convenient strategy of dimerization by microwave heating and using 2,5-diketopiperazine as scaffold

  2003cites this paper
• Trypsin induces tumour necrosis factor‐α secretion from a human leukemic mast cell line

  2003cites this paper
• [Physiological functions of protease-activated receptor-2].

  2003cites this paper
• Glycosylation and proteinase‐activated receptor function

  2003cites this paper
• The endothelium in clinical cardiac transplantation.

  2002cites this paper
• Induction of intestinal inflammation in mouse by activation of proteinase-activated receptor-2.

  2002cites this paper
• Effect of protease-activated receptor-2 deficiency on allergic dermatitis in the mouse ear.

  2002cites this paper
• Role of protease-activated receptors in airway function: a target for therapeutic intervention?

  2002cites this paper
• Fibers Selective Preservation in Ischemia / Reperfusion Injury : Involvement of Lipoxygenase Protease-Activated Receptor-2 Activation Causes EDHF-Like Coronary Vasodilation :

  2002cites this paper
• Protease-activated receptor-2 activating peptide SLIGRL inhibits bacterial lipopolysaccharide-induced recruitment of polymorphonuclear leukocytes into the airways of mice.

  2002cites this paper
• Human bronchial epithelial cells express PAR-2 with different sensitivity to thermolysin.

  2002cites this paper
• Glycoxidized low-density lipoprotein downregulates endothelial nitricoxide synthase in human coronary cells.

  2002cites this paper
• Enzymatic activation of endothelial protease‐activated receptors is dependent on artery diameter in human and porcine isolated coronary arteries

  2002cites this paper
• Negative inotropic mediators released from the heart after myocardial ischaemia-reperfusion.

  2002cites this paper
• Discovery of a nonpeptidic small molecule antagonist of the human platelet thrombin receptor (PAR-1).

  2002cites this paper